124 related articles for article (PubMed ID: 8487672)
1. Prospective evaluation of beta-cell function in insulin autoantibody-positive relatives of insulin-dependent diabetic patients.
Neifing JL; Greenbaum CJ; Kahn SE; McCulloch DK; Barmeier H; Lernmark A; Palmer JP
Metabolism; 1993 Apr; 42(4):482-6. PubMed ID: 8487672
[TBL] [Abstract][Full Text] [Related]
2. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study.
McCulloch DK; Klaff LJ; Kahn SE; Schoenfeld SL; Greenbaum CJ; Mauseth RS; Benson EA; Nepom GT; Shewey L; Palmer JP
Diabetes; 1990 May; 39(5):549-56. PubMed ID: 2185106
[TBL] [Abstract][Full Text] [Related]
3. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
Schmidli RS; Colman PG; Harrison LC
J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
[TBL] [Abstract][Full Text] [Related]
4. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
5. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes.
Atkinson MA; Maclaren NK; Scharp DW; Lacy PE; Riley WJ
Lancet; 1990 Jun; 335(8702):1357-60. PubMed ID: 1971659
[TBL] [Abstract][Full Text] [Related]
6. Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.
Greenbaum CJ; Sears KL; Kahn SE; Palmer JP
Diabetes; 1999 Jan; 48(1):170-5. PubMed ID: 9892239
[TBL] [Abstract][Full Text] [Related]
7. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Dittler J; Seidel D; Schenker M; Ziegler AG
Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
[TBL] [Abstract][Full Text] [Related]
8. Relationship between insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus: beta-cell function, islet cell antibody, and haptoglobin in parents of IDDM patients.
Kajio H; Kobayashi T; Nakanishi K; Okubo M; Tsukada T; Nakayama T; Yamada N; Murase T; Yazaki Y; Kosaka K
Metabolism; 1995 Jul; 44(7):869-75. PubMed ID: 7616845
[TBL] [Abstract][Full Text] [Related]
9. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
10. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
Bingley PJ
Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
[TBL] [Abstract][Full Text] [Related]
11. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
12. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
[TBL] [Abstract][Full Text] [Related]
13. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
[TBL] [Abstract][Full Text] [Related]
14. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
[TBL] [Abstract][Full Text] [Related]
15. Sexual dimorphism in transmission of expression of islet autoantibodies to offspring.
Yu L; Chase HP; Falorni A; Rewers M; Lernmark A; Eisenbarth GS
Diabetologia; 1995 Nov; 38(11):1353-7. PubMed ID: 8582546
[TBL] [Abstract][Full Text] [Related]
16. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
[TBL] [Abstract][Full Text] [Related]
18. Risk of progression to diabetes of low titer ICA-positive first-degree relatives of type I diabetics in southern Germany.
Ziegler AG; Baumgartl HJ; Standl E; Mehnert H
J Autoimmun; 1990 Oct; 3(5):619-24. PubMed ID: 2252530
[TBL] [Abstract][Full Text] [Related]
19. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
20. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
